Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24200,990,0.97 [0.89-1.06],0.4930987424085723
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24112,193,0.83 [0.69-1.02],0.0711017862914513
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26129,192,0.85 [0.70-1.03],0.0952927561303998
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18459,766,0.99 [0.90-1.09],0.8702183045952557
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26060,123,0.73 [0.57-0.94],0.0155494359499713
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24988,83,0.88 [0.66-1.19],0.41263013083336
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27508,122,0.74 [0.58-0.95],0.0191586263445937
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27502,82,0.86 [0.64-1.16],0.3262674232395501
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24361,65,1.01 [0.73-1.39],0.9556217126107784
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26825,120,0.94 [0.74-1.20],0.6281603030792641
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26776,71,0.89 [0.65-1.22],0.4587524743311822
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27586,78,1.13 [0.85-1.50],0.3876950566934822
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27552,100,1.12 [0.87-1.44],0.3867814961552027
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27547,95,1.16 [0.90-1.49],0.25692328601024
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Mycoses,27201,62,0.98 [0.70-1.36],0.8899298846670769
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26384,436,0.94 [0.83-1.07],0.3817370644739104
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26078,130,0.92 [0.73-1.16],0.4841938267825272
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26250,302,1.00 [0.86-1.16],0.9834663174859364
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22565,50,0.77 [0.52-1.13],0.1798909410507603
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22579,64,0.98 [0.71-1.35],0.8887276601305151
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22772,257,nan [nan-nan],
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22780,265,nan [nan-nan],
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23190,675,1.01 [0.91-1.12],0.8546822517762356
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22567,52,0.67 [0.45-0.99],0.0442635029569434
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24735,1027,0.99 [0.91-1.07],0.7772780224144039
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26507,294,1.00 [0.86-1.17],0.9833296387441608
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27243,109,0.92 [0.72-1.19],0.5404690139215063
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27679,90,0.92 [0.69-1.21],0.5394258740594705
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Rectum,27460,59,1.47 [1.10-1.98],0.0097531935091061
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27679,70,0.83 [0.60-1.15],0.2612976991363765
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Stomach,27726,55,0.88 [0.61-1.26],0.4887170379977424
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm,27499,270,0.98 [0.83-1.14],0.7557286258981385
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27673,106,1.13 [0.88-1.44],0.3330605198382885
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27674,107,0.79 [0.61-1.03],0.0843419631412887
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27605,70,0.82 [0.59-1.13],0.2282406547002127
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Haemangioma, any site",27607,69,0.86 [0.62-1.18],0.342909132573579
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanocytic naevi,27511,267,1.03 [0.88-1.21],0.6763118653042581
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27685,120,1.02 [0.80-1.28],0.8973410841667189
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Other benign neoplasms of skin,27574,229,1.15 [0.98-1.36],0.0969882570552566
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of breast,27663,140,0.83 [0.66-1.04],0.1073690819893617
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Leiomyoma of uterus,27150,996,1.02 [0.94-1.11],0.6444570454151008
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26316,269,1.04 [0.89-1.21],0.6395826786484142
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26040,447,1.02 [0.91-1.16],0.7037937794990963
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26040,447,1.02 [0.91-1.16],0.7037937794990963
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24481,408,0.99 [0.87-1.13],0.884353221215162
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27155,99,0.84 [0.64-1.10],0.1929741663401941
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27369,107,1.08 [0.85-1.38],0.5328036489926335
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22986,922,1.03 [0.95-1.13],0.472209881524289
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25383,899,1.00 [0.91-1.09],0.968321599009354
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25865,117,0.73 [0.56-0.94],0.0139374676000441
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26712,60,1.05 [0.76-1.47],0.7589233880334069
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25853,105,0.75 [0.58-0.99],0.0385396634662235
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26164,416,1.07 [0.94-1.22],0.3231214184957193
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26155,407,1.07 [0.94-1.22],0.3184373242850089
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25630,197,1.03 [0.84-1.26],0.7562240953425877
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25633,194,1.04 [0.85-1.27],0.6982598114610153
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22790,726,1.02 [0.92-1.13],0.6986639251264825
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22145,81,0.88 [0.65-1.19],0.4021562417524582
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22739,675,1.01 [0.91-1.12],0.7946126398189806
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22115,51,1.29 [0.92-1.80],0.1414346160960734
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22134,70,0.75 [0.54-1.04],0.0823323685179946
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Any mental disorder,23369,622,0.96 [0.86-1.07],0.4362178521018611
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22868,121,0.97 [0.76-1.25],0.8373406499891058
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27482,81,0.85 [0.62-1.15],0.2876564752008014
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27525,49,0.81 [0.54-1.21],0.3030475487104145
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26267,39,0.72 [0.46-1.13],0.1479916043830328
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27675,39,0.70 [0.45-1.10],0.1190349162466023
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22786,39,0.71 [0.45-1.12],0.1426563475724058
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Alcohol dependence,26254,26,0.62 [0.35-1.09],0.0972257821056965
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Smoking dependency,26146,36,1.10 [0.71-1.69],0.6805748033195833
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22790,43,0.91 [0.60-1.37],0.6457171657008405
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23132,385,0.96 [0.84-1.10],0.5617570105992957
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Depression,25700,342,0.93 [0.81-1.08],0.360193002759801
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Depression or dysthymia,22910,300,0.98 [0.84-1.14],0.8214770412874944
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22896,149,0.92 [0.74-1.15],0.4621660943461635
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Other anxiety disorders,25797,75,0.83 [0.60-1.13],0.2353503860202859
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Neurological diseases,23881,1639,1.06 [0.99-1.13],0.0745689226992715
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21841,184,0.96 [0.79-1.17],0.7142498302558405
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27525,152,1.00 [0.81-1.23],0.9893599025931752
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26376,427,0.98 [0.87-1.12],0.8046426337653684
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Epilepsy,26088,139,1.02 [0.82-1.27],0.8561092127811295
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Migraine,26077,128,0.90 [0.71-1.14],0.379162274309661
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27275,118,0.90 [0.70-1.14],0.3783300199685498
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27019,60,1.18 [0.85-1.62],0.3246632328358011
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other sleep disorders,26046,97,1.04 [0.80-1.35],0.7763147100697798
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Sleep apnoea,27307,70,1.00 [0.73-1.37],0.994152398210288
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26329,858,1.10 [1.01-1.20],0.034764806818366
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25590,119,1.16 [0.93-1.46],0.1959722787759891
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26017,546,1.09 [0.97-1.21],0.1395439026734014
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27463,76,0.96 [0.71-1.29],0.7729684504429303
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Hemiplegia,27444,57,0.87 [0.61-1.24],0.4509438338979615
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other neurological diseases,27232,124,0.92 [0.73-1.17],0.5074652625183511
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26977,425,0.96 [0.84-1.09],0.5103652201647748
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26801,249,0.99 [0.84-1.17],0.9135654027783522
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26624,72,0.88 [0.64-1.21],0.4398559200822025
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26686,134,1.01 [0.80-1.26],0.9586929644421568
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26657,105,1.21 [0.95-1.54],0.1154964285874908
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23541,182,1.15 [0.95-1.39],0.1438024095403306
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23781,422,1.05 [0.92-1.20],0.4440531610440634
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26671,183,1.11 [0.92-1.33],0.2894043684948975
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27454,33,0.82 [0.51-1.32],0.4221919179241337
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1782,33,0.74 [0.46-1.19],0.2114099582802794
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25705,33,0.83 [0.52-1.34],0.4479337652381662
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27006,92,1.07 [0.82-1.40],0.605314261440828
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26967,53,1.15 [0.82-1.62],0.4089728188509887
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26882,97,1.05 [0.81-1.36],0.7125840287541174
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27140,105,0.94 [0.73-1.21],0.6227832776703739
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27600,129,1.11 [0.89-1.38],0.3632354553102446
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26919,106,0.92 [0.71-1.19],0.5248597221935305
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20407,2804,1.02 [0.97-1.08],0.4533544534495974
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27140,77,0.76 [0.55-1.04],0.0841787177322369
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21447,2064,1.05 [0.99-1.12],0.1154942805227232
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypertension,21468,2085,1.05 [0.98-1.12],0.1359638322614406
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19432,49,0.95 [0.65-1.39],0.7918606352465661
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26026,727,0.94 [0.85-1.04],0.2227156090934399
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Angina pectoris,25804,505,0.93 [0.82-1.05],0.2443394276858175
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27057,150,0.88 [0.70-1.09],0.2396787277236888
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27135,228,0.86 [0.72-1.03],0.096129233323748
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27655,27,0.93 [0.56-1.55],0.7926565674874131
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25395,96,0.81 [0.61-1.07],0.1330477073906553
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25765,478,0.92 [0.82-1.05],0.2125968129105327
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26933,99,1.14 [0.89-1.47],0.2979343964635127
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27038,218,1.04 [0.88-1.24],0.6351887631948416
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26931,97,0.82 [0.62-1.08],0.1628060565990507
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26931,97,0.82 [0.62-1.08],0.1628060565990507
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19477,94,0.84 [0.63-1.11],0.2106019086342174
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24069,40,1.12 [0.75-1.67],0.5724940041871327
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Conduction disorders,24110,81,1.06 [0.79-1.41],0.7053287672551989
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16651,104,0.92 [0.71-1.19],0.5284375369296543
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16827,280,0.83 [0.70-0.98],0.0317781762978773
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other arrhythmias,24079,50,0.79 [0.54-1.16],0.2368246463758746
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24086,57,0.60 [0.41-0.87],0.0076820433837061
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26876,102,0.95 [0.73-1.24],0.7115068047232251
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26938,131,0.77 [0.60-0.98],0.030327246224761
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26978,99,0.75 [0.56-0.98],0.0380976663882825
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27046,87,0.78 [0.58-1.05],0.0996266711005122
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26736,71,1.05 [0.78-1.43],0.7319968839966571
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26778,113,0.81 [0.63-1.05],0.1120082064536431
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26100,133,1.00 [0.80-1.25],0.9967366401797564
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26073,106,1.04 [0.81-1.33],0.7671883174821598
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27515,103,1.01 [0.78-1.31],0.9224439011530436
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Varicose veins,26582,615,0.89 [0.80-0.99],0.0365344048393612
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypotension,26565,92,0.78 [0.59-1.04],0.0903413919127542
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22528,2121,1.06 [1.00-1.13],0.0515961548809646
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27507,132,1.11 [0.89-1.38],0.3435509373758935
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26074,198,0.99 [0.82-1.19],0.9304494113446335
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26055,179,1.06 [0.87-1.28],0.5585899629261266
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26812,232,0.89 [0.75-1.07],0.2131835885023588
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26804,224,0.88 [0.73-1.05],0.1539147581136322
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26947,569,1.04 [0.93-1.16],0.4756214499592882
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Chronic sinusitis,26492,114,1.08 [0.85-1.37],0.5357062810243192
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Nasal polyp,26460,82,0.90 [0.67-1.21],0.4983360108570541
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26738,360,1.08 [0.94-1.24],0.2603399000835456
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Deviated nasal septum,26520,142,1.19 [0.97-1.46],0.1025114265165481
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13342,65,1.05 [0.76-1.46],0.7577415626147157
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24741,1172,1.10 [1.02-1.19],0.0116125332014914
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Early onset COPD,26651,158,1.23 [1.01-1.51],0.0406670021574878
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26671,178,1.15 [0.95-1.40],0.1498801255629682
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26671,178,1.15 [0.95-1.40],0.1498801255629682
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25651,1008,1.09 [1.01-1.18],0.0370806808029299
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Asthma,20585,1008,1.10 [1.01-1.20],0.0234270886034239
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20393,1008,1.10 [1.01-1.20],0.0241116132458819
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20570,993,1.09 [1.01-1.19],0.036285514730247
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27395,84,1.15 [0.88-1.51],0.3104761562381541
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Interstitial lung disease,25923,63,1.17 [0.86-1.60],0.3116780184908138
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27472,63,1.18 [0.87-1.61],0.2919650943511448
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25916,56,1.08 [0.77-1.51],0.6554296903062229
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pleural effusion,25861,88,0.89 [0.67-1.18],0.4266556756677053
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other diseases of pleura,25967,194,1.03 [0.85-1.24],0.7690931277105528
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26543,92,1.14 [0.88-1.48],0.3325110563087868
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19180,6051,1.03 [0.99-1.07],0.159711035533035
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27147,472,0.97 [0.86-1.09],0.6060739900665186
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27680,103,0.90 [0.69-1.17],0.4246565400601503
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Impacted teeth,27685,93,0.92 [0.70-1.21],0.5569567255938359
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Dental caries,26780,105,0.91 [0.70-1.18],0.4812308903263025
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26792,117,1.11 [0.88-1.41],0.3604939523502291
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27671,114,0.96 [0.76-1.23],0.7716504630486277
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26793,118,1.02 [0.80-1.29],0.8737372543655584
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26486,77,0.94 [0.70-1.27],0.6854894643899039
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27585,48,0.96 [0.66-1.40],0.8297696398922191
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20932,221,0.91 [0.76-1.09],0.309663342760797
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23046,2335,1.00 [0.95-1.06],0.8933884763978001
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oesophagitis,20999,288,1.16 [1.00-1.34],0.0549428560439879
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21456,745,1.02 [0.93-1.12],0.6861002470890362
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20789,78,1.09 [0.82-1.46],0.5367415446838041
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20846,135,1.12 [0.90-1.39],0.3028893691980349
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20752,41,1.12 [0.76-1.66],0.5557026109054464
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastric ulcer,20860,149,0.96 [0.77-1.19],0.7100377814391938
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Duodenal ulcer,20784,73,0.87 [0.64-1.20],0.4053910322717432
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27633,51,0.71 [0.48-1.05],0.085099148804151
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Chronic gastritis,20848,137,1.02 [0.81-1.27],0.885612899794905
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21565,854,1.01 [0.92-1.10],0.8714846671428003
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of appendix,27559,146,1.17 [0.95-1.43],0.1313269393720833
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Functional dyspepsia,21290,579,0.97 [0.87-1.08],0.5525680551886591
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20893,182,1.05 [0.87-1.27],0.6016281256185914
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27594,143,0.87 [0.70-1.09],0.2169477609333232
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute appendicitis,27530,117,1.11 [0.88-1.39],0.3929882382348094
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Hernia,24804,1209,1.05 [0.98-1.14],0.1825686956147536
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Inguinal hernia,23663,68,0.97 [0.71-1.34],0.8710287734074446
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Umbilical hernia,23668,73,1.13 [0.84-1.53],0.4102567353621545
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ventral hernia,23705,110,1.09 [0.86-1.39],0.4837631553735821
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24560,965,1.07 [0.99-1.17],0.1058175182526306
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26631,922,1.06 [0.97-1.15],0.1843187134896946
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of intestines,21936,2216,1.03 [0.97-1.09],0.3658209403266822
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27368,64,1.39 [1.05-1.85],0.0237339493107781
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27652,93,1.20 [0.93-1.54],0.1692581139180907
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Crohn disease,25802,93,1.20 [0.93-1.55],0.1539981635300692
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25777,68,1.08 [0.79-1.47],0.6348833636796475
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27572,135,1.11 [0.90-1.38],0.3379883707214539
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ulcerative colitis,25844,135,1.12 [0.90-1.39],0.3044922743012389
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25830,121,1.06 [0.84-1.34],0.6268733567592972
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26488,779,1.04 [0.95-1.14],0.4290724038361553
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26477,768,1.04 [0.94-1.14],0.4634504488692271
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19828,108,1.04 [0.81-1.34],0.742010998464552
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Intestinal stricture,27244,108,1.04 [0.81-1.33],0.781598486596204
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19787,67,1.08 [0.79-1.47],0.6471605454744139
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20399,679,1.12 [1.02-1.24],0.0231760081431401
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19967,247,1.07 [0.91-1.26],0.4033027498476909
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20115,395,1.06 [0.94-1.21],0.3429988534483263
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Constipation,25998,351,1.07 [0.93-1.23],0.3251679716548693
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27197,123,1.11 [0.89-1.39],0.3606527334749116
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19845,125,0.92 [0.73-1.17],0.5055659442295768
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19768,48,0.77 [0.52-1.14],0.1902252740580217
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20622,902,0.98 [0.90-1.07],0.6748794000381224
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of intestine,19955,235,0.99 [0.84-1.18],0.9483431680580172
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27180,106,1.12 [0.88-1.43],0.3730591106880829
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of liver,26923,105,0.55 [0.41-0.72],2.3530289272759148e-05
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of liver,26872,54,0.60 [0.41-0.88],0.0097577249905519
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26137,889,1.08 [0.99-1.18],0.0812071742717608
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Cholelithiasis,25990,742,1.11 [1.01-1.22],0.0272614326822121
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Cholecystitis,25384,136,1.19 [0.96-1.47],0.10953767269775
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25318,70,0.88 [0.64-1.22],0.4521551923957144
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute pancreatitis,25311,63,1.08 [0.78-1.50],0.6304465802184449
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27564,63,1.07 [0.77-1.48],0.6799310558817444
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26314,309,1.08 [0.94-1.25],0.2827176385015421
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26109,104,1.00 [0.77-1.29],0.9899796621623368
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Coeliac disease,26093,88,1.02 [0.77-1.34],0.91522888043741
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26045,40,1.10 [0.74-1.65],0.6296004601567378
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26175,170,1.15 [0.95-1.39],0.1631953302914043
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,GI-bleeding,26165,160,1.15 [0.94-1.40],0.1763059019926954
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24544,1628,0.95 [0.89-1.02],0.1508465833588602
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27257,116,0.87 [0.68-1.12],0.2873795113634215
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27256,458,1.02 [0.90-1.15],0.7868162269048387
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26135,700,0.93 [0.84-1.03],0.152904143540741
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26889,325,0.96 [0.83-1.11],0.5817680766056279
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26635,71,0.93 [0.68-1.27],0.6360261848557435
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26771,207,0.91 [0.75-1.09],0.3136025723868125
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27428,91,1.16 [0.89-1.50],0.2757821883103419
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27400,63,1.14 [0.83-1.56],0.4271434515655538
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27387,50,1.10 [0.77-1.57],0.5913645291006615
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27446,56,0.85 [0.59-1.22],0.3742304293644336
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27443,53,0.84 [0.58-1.22],0.3625041396292726
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26857,59,1.14 [0.82-1.58],0.4271251956153158
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27156,358,1.03 [0.90-1.18],0.6655385760462119
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25538,103,1.02 [0.79-1.32],0.8772071276025357
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25593,158,0.79 [0.63-0.98],0.0315825758001853
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25549,114,0.88 [0.68-1.13],0.3223015358405402
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25691,256,0.97 [0.82-1.14],0.6978391186270427
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25665,230,0.95 [0.80-1.14],0.6027259105654603
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19527,4435,1.00 [0.95-1.04],0.8983770235561325
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21272,2555,1.01 [0.95-1.06],0.837735108813682
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24885,1344,1.05 [0.98-1.13],0.1495871804122741
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18927,210,1.05 [0.88-1.26],0.5778263184959229
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19240,523,1.04 [0.93-1.17],0.5097178851573216
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27133,202,1.08 [0.90-1.29],0.4158322412274878
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27150,184,1.07 [0.89-1.30],0.4569319708017528
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19953,1236,1.07 [0.99-1.16],0.0706757683166424
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22689,1236,1.07 [0.99-1.16],0.0816143646253265
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18729,12,0.72 [0.32-1.64],0.4406788694442453
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27518,12,0.68 [0.30-1.56],0.3651845823007177
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18999,282,1.11 [0.95-1.29],0.1765871411728403
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18804,87,1.10 [0.83-1.44],0.5096360221982235
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19024,307,1.14 [0.99-1.32],0.0779307284138338
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27520,156,1.24 [1.02-1.51],0.0323541457800691
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19207,490,1.08 [0.96-1.22],0.1842305526055533
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19208,491,1.00 [0.89-1.13],0.9878685613045488
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20147,1430,0.95 [0.88-1.02],0.1456446942754193
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18825,108,0.78 [0.60-1.02],0.0669558028623405
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19145,428,0.89 [0.78-1.02],0.082855759924366
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18799,82,0.88 [0.65-1.18],0.3968489786113159
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18825,108,1.11 [0.87-1.42],0.4097348057171027
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19095,378,1.08 [0.95-1.24],0.2433440730575952
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19038,321,1.07 [0.92-1.23],0.3865818886685548
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20655,299,0.92 [0.79-1.07],0.2859313854999875
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26891,221,0.71 [0.59-0.86],0.0004133851506271
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26762,92,1.15 [0.89-1.49],0.2823199320165853
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23717,84,1.08 [0.82-1.43],0.5870740298494943
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23941,308,1.00 [0.86-1.16],0.9952239838537684
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24663,1030,0.99 [0.91-1.07],0.7874936379889946
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23850,217,1.03 [0.87-1.23],0.7258704418436033
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23711,78,1.05 [0.78-1.41],0.7399202269230385
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24451,818,1.01 [0.92-1.10],0.8903801772733316
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23682,49,1.16 [0.81-1.66],0.4149374356044739
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23876,243,1.14 [0.97-1.34],0.1165884620205261
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23735,102,1.18 [0.93-1.51],0.1774452989098764
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23725,92,0.96 [0.73-1.26],0.7524591703165955
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23797,164,0.88 [0.72-1.09],0.2351370556348432
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23707,74,1.05 [0.78-1.42],0.7351934140415728
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23989,356,1.06 [0.92-1.21],0.422919425695014
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23925,384,1.05 [0.92-1.20],0.4252599329592483
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23613,72,0.93 [0.68-1.27],0.6367094126578647
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23651,110,0.94 [0.73-1.21],0.6434088179532717
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23683,142,1.21 [0.99-1.49],0.0669586957474156
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23580,39,1.16 [0.78-1.73],0.4561859300859041
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23600,59,1.21 [0.88-1.66],0.2362065900215786
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23584,43,0.88 [0.59-1.33],0.5452222620334428
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23823,282,1.06 [0.91-1.23],0.4770183569595939
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23602,61,1.23 [0.90-1.68],0.2002774260099884
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23609,68,1.00 [0.73-1.37],0.9990829384733994
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23681,140,1.10 [0.89-1.36],0.4005289568178012
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23623,82,0.92 [0.69-1.24],0.5935921253266645
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24087,546,1.01 [0.90-1.13],0.8758101625763214
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23734,193,0.94 [0.77-1.13],0.5093191863630604
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23835,294,1.05 [0.90-1.22],0.5440199198935268
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24948,239,0.86 [0.72-1.03],0.0964106224269408
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25202,493,0.88 [0.78-1.00],0.0430235450256116
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24749,40,0.81 [0.53-1.24],0.332328689823126
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24777,68,0.71 [0.51-0.99],0.0432142905394927
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24828,119,0.87 [0.68-1.12],0.2790865876835477
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22626,6156,0.99 [0.95-1.03],0.5940640210948269
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25241,202,1.00 [0.83-1.20],0.975466677320976
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25085,46,1.31 [0.92-1.86],0.1281965595104267
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25416,34,1.15 [0.75-1.76],0.5234734908939529
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25431,49,0.96 [0.66-1.40],0.8239222882523165
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25423,41,0.94 [0.62-1.42],0.7790196988708009
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27475,133,0.91 [0.72-1.15],0.4212806236244072
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27351,68,1.05 [0.77-1.44],0.7438563219496903
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27442,100,1.00 [0.77-1.30],0.999392548650632
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27380,38,0.66 [0.42-1.04],0.0735705028813253
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25474,1253,1.02 [0.95-1.10],0.6217022390814086
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Cystitis,24358,137,1.06 [0.85-1.32],0.6001090797051158
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24308,87,1.02 [0.77-1.35],0.8850986068295863
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24389,168,1.23 [1.02-1.48],0.0344061025587374
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24310,89,0.88 [0.67-1.17],0.3976049185401431
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25207,986,1.01 [0.93-1.10],0.809182116095778
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27404,483,0.92 [0.82-1.04],0.1777063315837178
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27071,150,0.98 [0.79-1.21],0.833371900502772
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27092,171,0.92 [0.75-1.12],0.4029327102946914
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27035,114,0.83 [0.64-1.07],0.1484200845125002
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27343,560,0.98 [0.88-1.10],0.7701379004938614
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26916,133,0.84 [0.67-1.06],0.1498767401472391
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27034,251,1.05 [0.89-1.23],0.5695402446511888
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25272,4608,1.00 [0.96-1.04],0.9594716391606
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Endometriosis,21027,363,1.11 [0.97-1.27],0.1152823191790126
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20761,97,1.10 [0.85-1.42],0.4747510597615212
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20834,170,1.25 [1.04-1.51],0.0180701960278635
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21464,800,1.02 [0.93-1.12],0.6309766394167017
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21075,411,1.10 [0.97-1.24],0.1536166650382995
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21627,963,0.95 [0.87-1.03],0.2075962271198447
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20981,317,0.83 [0.71-0.97],0.0187520457640741
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21105,441,1.04 [0.92-1.17],0.5597115758744673
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20764,100,0.95 [0.73-1.23],0.6835930950495459
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20854,190,1.12 [0.93-1.34],0.2298968503193261
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27679,268,1.09 [0.94-1.28],0.2591157075869392
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27691,254,1.11 [0.95-1.30],0.1886761555677089
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27716,141,1.07 [0.86-1.32],0.5544926151680848
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27705,155,1.04 [0.85-1.28],0.7011972787644736
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20806,142,0.98 [0.79-1.22],0.8555272697343209
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20779,115,0.83 [0.65-1.07],0.1495003122202268
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20808,144,1.05 [0.85-1.30],0.6266618503334345
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Irregular menses,27613,468,1.07 [0.95-1.20],0.2735782623284836
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22004,1340,1.01 [0.94-1.09],0.7753317039058578
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21537,873,1.01 [0.93-1.11],0.7758953539131768
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27699,197,0.98 [0.81-1.17],0.7961337405030776
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21136,472,0.96 [0.85-1.08],0.4838931917306809
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20993,329,0.94 [0.81-1.09],0.3939873365981166
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21564,900,0.97 [0.88-1.06],0.477495205701242
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Female infertility,20780,116,1.13 [0.89-1.42],0.3143593304887382
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20773,109,1.13 [0.89-1.44],0.3203362364093737
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27713,881,0.99 [0.90-1.08],0.7702011274791922
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27717,1202,0.99 [0.91-1.08],0.8229998207223427
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27714,480,1.01 [0.89-1.14],0.8644729618029267
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27370,136,0.93 [0.74-1.16],0.5203898243369243
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27426,192,0.96 [0.79-1.16],0.6711392409160333
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27400,166,1.02 [0.84-1.25],0.8345448011305696
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27732,166,1.00 [0.82-1.22],0.9696257125199874
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27734,164,1.00 [0.82-1.22],0.9880452698885762
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27731,417,0.97 [0.85-1.11],0.6379130123951924
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27440,126,0.78 [0.61-0.99],0.0445689375767436
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27544,230,1.02 [0.85-1.21],0.8648884110322326
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26981,149,1.00 [0.81-1.24],0.9743992203476932
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27036,204,0.91 [0.75-1.10],0.3254506979021039
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27083,251,0.97 [0.82-1.15],0.7096281185454947
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26980,148,1.03 [0.83-1.28],0.7811487503406049
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26971,139,0.97 [0.78-1.21],0.8030678217762766
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26980,148,0.97 [0.78-1.20],0.7663444726268936
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26747,232,0.99 [0.83-1.17],0.8821380147824943
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26950,435,0.94 [0.82-1.07],0.3588241981543031
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27185,670,1.01 [0.90-1.12],0.921442712393872
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27735,171,1.01 [0.83-1.23],0.9304453643461664
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26271,130,0.97 [0.77-1.22],0.7926966458135536
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26618,103,0.89 [0.69-1.16],0.4043935062919013
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27743,343,0.97 [0.84-1.12],0.6909612516740163
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27660,260,0.90 [0.76-1.07],0.2279000764254424
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27730,253,1.02 [0.86-1.20],0.836516967079592
BID,BH3-interacting domain death agonist,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27720,243,1.02 [0.87-1.21],0.7854310805734013
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27441,44,0.70 [0.46-1.06],0.0896686020424009
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24798,646,0.88 [0.79-0.97],0.014541013707038
